nach oben

AIDS and Behavior

Erschienen in:

02.03.2023 | Original Paper

Attitudes and Beliefs About HIV Treatment as Prevention Among People Who are Not Engaged in HIV Care, 2018–2019

verfasst von: Mabel Padilla, Mariana Gutierrez, Mohua Basu, Jennifer Fagan

Erschienen in: AIDS and Behavior | Ausgabe 9/2023

Einloggen, um Zugang zu erhalten

Abstract

Treatment as prevention (TasP) is an effective HIV prevention strategy. Our objectives were to explore TasP attitudes and beliefs among people with HIV (PWH) who are not engaged in care and to examine attitudes and beliefs by selected characteristics. We sampled PWH who had participated in the Medical Monitoring Project (MMP), a structured interview survey, from June 2018–May 2019 to participate in 60-minute semi-structured telephone interviews. We obtained sociodemographic and behavioral quantitative data from the MMP structured interview. We used applied thematic analysis to analyze the qualitative data and integrated the qualitative and quantitative data during analysis. Negative attitudes and beliefs, especially skepticism and mistrust, about TasP were pervasive. Only one participant who identified as female, was not sexually active, and had not heard of TasP held positive attitudes and beliefs about TasP. TasP messages should use clear and unambiguous language, address mistrust, and reach people who are not engaged in medical care.

HIV Treatment as prevention. https://www.hiv.gov/tasp. Updated June 17, 2022. Accessed July 20, 2022.

Cohen MS, Chen YQ, McCauley M, et al. Antiretroviral therapy for the prevention of HIV-1 transmission. N Engl J Med. 2016;375:830–9. https://doi.org/10.1056/NEJMoa1600693CrossRefPubMedPubMedCentral

Bavinton BR, Pinto AN, Phanuphak N, et al. Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study. Lancet HIV. 2018;5(8):e438–47. https://doi.org/10.1016/S2352-3018(18)30132-2CrossRefPubMed

Rodger AJ, Cambiano V, Bruun T, et al. Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy. JAMA. 2016;316(2):171–81. https://doi.org/10.1001/jama.2016.5148CrossRefPubMed

Cambiano RA, Bruun T, Vernazza P, et al. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study. The Lancet. 2019;393(10189):2428–38.CrossRef

Prevention Access Campaign. https://preventionaccess.org/about-introduction/. Accessed January 17, 2023.

Matacotta J, Rosales-Perez F, Carillo C. HIV preexposure prophylaxis and treatment as Prevention — beliefs and access barriers in men who have sex with men (MSM) and transgender women: a systematic review. J Patient-Centered Res Reviews. 2020;7(3):265–74.CrossRef

Glan K, Rimer BK, Viswanath K, editors. Health Behavior and Health Education: theory, Research, and practice. 4th ed. San Francisco, Ca: Jossey-Bass; 2008.

Rendina JH, Talan AJ, Cienfuegos-Szalay J, Carter JA, Shalhav O. Treatment is more than prevention: perceived personal and social benefits of undetectable = untransmittable messaging among sexual minority men living with HIV. AIDS Patient Care STDS. 2020;34(10):444–51. https://doi.org/10.1089/apc.2020.0137CrossRefPubMedPubMedCentral

10.

Card K, Armstrong H, Lachowsky N, et al. Belief in treatment as prevention and its relationship to HIV status and behavioral risk. J Acquir Immune Defic Syndr. 2018;77(1):8–16. https://doi.org/10.1097/QAI.0000000000001557CrossRefPubMedPubMedCentral

11.

Bor J, Fischer C, Modi M, et al. Changing knowledge and attitudes towards HIV Treatment-as-Prevention and “Undetectable = Untransmittable”: a systematic review. AIDS Behav. 2021;25(12):4209–24. https://doi.org/10.1007/s10461-021-03296-8CrossRefPubMedPubMedCentral

12.

Grace D, Nath R, Parry R, Connell J, Wong J, Grennan T. ‘… if U equals U what does the second U mean?’: sexual minority men’s accounts of HIV undetectability and untransmittable scepticism. Culture, Health, & Sexuality. 2021;23(9): 1270–1286. https://doi.org/10.1080/13691058.2020.1776397

13.

Meanley S, Connochie D, Bonett S, Flores D, Bauermeister J. Awareness and perceived accuracy of undetectable = untransmittable: a cross-sectional analysis with implications for treatment as prevention among young men who have sex with men. Sex Transm Dis. 2019;46(11):733–6. https://doi.org/10.1097/OLQ.0000000000001048CrossRefPubMedPubMedCentral

14.

Siegel K, Meunier E. Awareness and perceived effectiveness of HIV Treatment as Prevention among men who have sex with men in New York City. AIDS Beh. 2019;23(7):1974–83. https://doi.org/10.1097/QAI.0000000000001557CrossRef

15.

Meunier E, Siegel K, Sundelson A, Schrimshaw E. Stages of adoption of “treatment as Prevention” among HIV-Negative men who have sex with men who engage in Exchange Sex. AIDS Patient Care STDS. 2020;34(9):380–91. https://doi.org/10.1089/apc.2020.0062CrossRefPubMedPubMedCentral

16.

Rendina H, Parsons J. Factors associated with perceived accuracy of the undetectable = untransmittable slogan among men who have sex with men: implications for messaging scale-up and implementation. J Int AIDS Soc. 2018;21(1):e25055. https://doi.org/10.1002/jia2.25055CrossRefPubMedPubMedCentral

17.

Rendina JH, Cienfuegos-Szalay J, Talan A, Scott Jones S, Jimenez RH. Growing acceptability of undetectable = untransmittable but widespread misunderstanding of transmission risk: findings from a very large sample of sexual minority men in the United States. J Acquir Immune Defic Syndr. 2020;83(3):215–22. https://doi.org/10.1097/QAI.0000000000002239CrossRefPubMedPubMedCentral

18.

Newman C, de Wit J, Persson A, Holt M, Slavin S, Kidd M, et al. Understanding concerns about treatment-as-Prevention among People with HIV who are not using antiretroviral therapy. AIDS and Behav. 2015;19(5):821–31. https://doi.org/10.1007/s10461-014-0959-9CrossRef

19.

Carneiro P, Westmoreland D, Patel V, Grov C. Awareness and acceptability of undetectable = untransmittable among a U.S. national sample of HIV-negative sexual and gender minorities. AIDS Beh. 2021;25(2):634–44.CrossRef

20.

Beer L, Johnson CH, Fagan JL, et al. A national behavioral and clinical surveillance system of adults with diagnosed HIV (The Medical Monitorign Project): protocol for an annual cross-sectional interview and medical record abstraction survey. JMIR Rese Protoc. 2019;8(11):e15453. https://doi.org/10.2196/15453CrossRef

21.

Padilla M, Gutierrez M, Fagan J. Using semistructured telephone interviews to collect qualitative data from people with HIV who are not in medical care: implementation study. JMIR Res Protoc. 2022;11(11):e40041. https://doi.org/10.2196/40041CrossRefPubMedPubMedCentral

22.

Creswell JW, Plano Clark VL. Designing and conducting mixed methods research. 3rd ed. Thousand Oaks, CA: SAGE Publications, 2017. https://books.google.com/books?hl=en&lr=&id=BXEzDwAAQBAJ&oi=fnd&pg=PP1&ots=UkzbHnjvoz&sig=pdEZVXGw66CUfaAWTtJiYlj3JZo#v=onepage&q&f=false. Accessed August 10, 2022.

23.

Fetters MD, Curry LA, Creswell JW. Achieving integration in mixed methods designs-principles and practices. Health Serv Res. 2013;48(6 Pt 2):2134–56. https://doi.org/10.1111/1475-6773.12117CrossRefPubMedPubMedCentral

24.

Sauermilch D, Siegel K, Hoppe T, Roth G, Meunier E. Attitudes towards HIV-positive status disclosure among U = U-aware sexual and gender minority individuals in the USA: a consensual qualitative research approach. Sex Res Social Policy. 2022;1–13. https://doi.org/10.1007/s13178-022-00710-1

25.

Ending the HIV Epidemic in the U.S. (EHE). Centers for Disease Control and Prevention. Updated June 13., 2022. https://www.cdc.gov/endhiv/treat.html. Accessed July 20, 2022.

26.

Kalichman SC, Kalichman MO, Easton LA. Undisclosed HIV status to sex partners and its unintended consequences in the era of undetectable = untransmittable. J Acquir Immune Defic Syndr. 2021;88(2):149–56. https://doi.org/10.1097/QAI.0000000000002762CrossRefPubMed

27.

Okoli C, Van de Velde N, Richman B, et al. Undetectable equals untransmittable (U = U): awareness and associations with health outcomes among people living with HIV in 25 countries. Sex Trans Infect. 2021;97(1):18–26. https://doi.org/10.1136/sextrans-2020-054551CrossRef

28.

Hascher K, Jaiswal J, Lorenzo J, et al. ‘Why aren’t you on PrEP? You’re a gay man’: reification of HIV ‘risk’ influences perception and behavior of young sexual minority men and medical providers. Cult Health Sex. 2021;1–15. https://doi.org/10.1080/13691058.2021.2018501

29.

Calabrese SK, Mayer KH, Marcus JL. Prioritising pleasure and correcting misinformation in the era of U = U. Lancet HIV. 2021;8(3):e175–80. https://doi.org/10.1016/S2352-3018(20)30341-6CrossRefPubMedPubMedCentral

30.

Schwartz J, Grimm J. Investigating the content of #UequalsU on Twitter. Health Commun. 2021;1–9. https://doi.org/10.1080/10410236.2021.2006395

31.

Rivera AV, Carillo SA, Braunstein SL. Prevalence of U = U awareness and its association with anticipated HIV stigma among low-income heterosexually active black and latino adults in New York City, 2019. AIDS Patient Care STDS. 2021;35(9):370–6. https://doi.org/10.1089/apc.2021.0070CrossRefPubMed

Titel: Attitudes and Beliefs About HIV Treatment as Prevention Among People Who are Not Engaged in HIV Care, 2018–2019
verfasst von: Mabel Padilla
Mariana Gutierrez
Mohua Basu
Jennifer Fagan
Publikationsdatum: 02.03.2023
Verlag: Springer US
Erschienen in: AIDS and Behavior / Ausgabe 9/2023
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI: https://doi.org/10.1007/s10461-023-04032-0

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Attitudes and Beliefs About HIV Treatment as Prevention Among People Who are Not Engaged in HIV Care, 2018–2019

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2023

HIV Risk Perception, Willingness to Use PrEP, and PrEP Uptake Among Young Men who have Sex with Men in Washington, DC

Variations in Pre-exposure Prophylaxis (PrEP) Awareness and Healthcare Provider Interactions in a Nationally Representative Sample of American Men Aged 15–49 Years: A Cross-Sectional Study

Barriers to Condom Negotiation and Use Among Female Sex Workers in the United States and United States-Mexico Border Cities: A Systematic Review

The Moderating Role of Social Support and HIV Stigma on the Association Between Depression and ART Adherence Among Young Thai Men Who Have Sex with Men

Who is Exposed to HIV Prevention Interventions? An Assessment of Associated Factors Among Adolescent Girls and Young Women in South Africa

Effects of M-DEPTH Model of Depression Care on Maternal HIV Viral Suppression and Adherence to the PMTCT Care Continuum Among HIV-Infected Pregnant Women in Uganda: Results from a Cluster Randomized Controlled Trial at Pregnancy Completion

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin